Enzyme ImmunoAssay (ELISA) for the determination of IgA antibodies to COVID19 in human plasma and sera.
The IgA assay is recommended, in addition to IgG and IgM, to:
- a) monitor the global immunological response of patients undergoing an acute infection and their follow-up to full recovery;
- b) and specifically for testing patients with symptoms of the gastro enteric form of COVID-19 infection.
For “in vitro” diagnostic use only.